Engineers Gate Manager’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Engineers Gate Manager's FLNA Position: Q1 2026 in Review
Engineers Gate Manager increased its Filana Therapeutics (FLNA) stake by 25% in Q1 2026, buying an estimated $16.1K and bringing the position to 39,494 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.
Engineers Gate Manager first reported a position in FLNA in Q1 2021 and has held it in 8 quarters since. The position peaked at $838K in Q4 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Engineers Gate Manager held 39,494 shares of Filana Therapeutics worth $66.7K as of Q1 2026.
- Engineers Gate Manager bought 7,840 Filana Therapeutics shares in Q1 2026, an estimated $16.1K.
- Filana Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2068 holding.
- Engineers Gate Manager first reported a position in Filana Therapeutics in Q1 2021 and has held it in 8 quarters since.
- Engineers Gate Manager's Filana Therapeutics position peaked at $838K in Q4 2023.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.